Trials / Withdrawn
WithdrawnNCT01170507
Magnitude of Changes in 25 OH Vitamin D3 Levels After Vitamin D3 Supplementation
Magnitude of Changes in 25 OH Vitamin D3 Levels After Vitamin D3 Supplementation: A Randomized Controlled Study
- Status
- Withdrawn
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- King Faisal Specialist Hospital & Research Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Vitamin D deficiency is common world wide. 25 OH vitamin D level is the best indicator of vitamin D status. The determination of the appropriate dose of vitamin D supplement is essential for management of vitamin D deficiency as well as for designing vitamin D fortification programs. The increments in 25 OH vitamin D levels following various doses of vitamin D supplement for different genders, body weights, and starting 25 OH vitamin D level have not been well defined. The time course of depletion of repleted vitamin D stores is also not known. The investigators plan to conduct a double blind randomized study on 9 cohorts to determine levels of 25 OH vitamin D following supplementation with different doses of vitamin D3 for 5 months and their withdrawal for 3 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | vitamin D3 1000 IU orally daily for 5 months | |
| DRUG | vitamin D3 3000 IU orally daily for 5 months | |
| DRUG | vitamin D3 5000 IU orally daily for 5 months | |
| DRUG | Placebo orally daily for 5 months |
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2016-08-01
- Completion
- 2016-08-01
- First posted
- 2010-07-27
- Last updated
- 2018-03-07
Locations
1 site across 1 country: Saudi Arabia
Source: ClinicalTrials.gov record NCT01170507. Inclusion in this directory is not an endorsement.